TOLREMO therapeutics
Jessica Corson serves as the Chief Business Officer at TOLREMO Therapeutics and holds a position as a Board Member at RS Oncology. Previously, Jessica held the role of Associate Director of Business Development at Amylin Pharmaceuticals and was a Business Development & Marketing Associate at eBioscience, an Affymetrix company. Jessica's extensive experience in business development and marketing within the pharmaceutical sector underscores a strong background in strategic business growth and partnership development.
This person is not in any teams
This person is not in any offices
TOLREMO therapeutics
TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.